Stock Information
Compass Pathways PLC (CMPS)
Ticker Symbol: CMPS
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,790.78 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -3.47
Revenue (TTM): $0.00 M
Dividend Yield: N/A
ROE: -200.74%
Latest News
-
Compass Pathways Targets Q4 COMP360 NDA Completion, Eyes 2027 Launch
Fri, Sep 25, 2026 12:02 AM
-
Helus Pharma Eyes Q4 Phase III Data for HLP-003 in Major Depression
Thu, Sep 24, 2026 10:02 AM
-
Compass Pathways Targets 2027 COMP360 Launch After Positive Phase III Depression Data
Tue, Sep 22, 2026 9:02 PM
-
Compass Pathways Eyes 2027 COMP360 Launch as FDA Review Advances
Tue, Sep 22, 2026 7:02 PM
-
Cybin Shareholders Weigh Helus Pharma Rebrand, Eight-Member Board
Tue, Sep 22, 2026 1:02 PM
-
Compass Pathways Eyes 2027 COMP360 Launch as FDA Filing Nears
Tue, Sep 22, 2026 6:02 AM
Key Financials
Financial data not available
